Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - biotinum - tabletki - 10 mg

Unia Europejska - polski - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil chlorowodorek - nowotwory jelita grubego - Środki przeciwnowotworowe - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Unia Europejska - polski - EMA (European Medicines Agency)

actavis group ptc ehf - topotekan - uterine cervical neoplasms; small cell lung carcinoma - Środki przeciwnowotworowe - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. topotekanu w połączeniu z cisplatyną jest wskazany dla pacjentów z rakiem nawracające szyjki macicy po radioterapii dla pacjentów stadium choroby, ИВБ . patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.

Unia Europejska - polski - EMA (European Medicines Agency)

actavis group ptc ehf - reteplase - zawał mięśnia sercowego - Środki przeciwzakrzepowe - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Unia Europejska - polski - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - Środki antybakteryjne do stosowania systemowego, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. należy uwzględnić oficjalne zalecenia dotyczące właściwego stosowania antybiotyków agentów. odpowiedniego stosowania środków przeciwbakteryjnych.

Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

synoptis pharma sp. z o.o. - nebivololi hydrochloridum - tabletki - 5 mg

Unia Europejska - polski - EMA (European Medicines Agency)

roche registration gmbh - polatuzumab ведотин - chłoniak b-komórkowy - Środki przeciwnowotworowe - Полевий w połączeniu z Бендамустин i rytuksymab jest wskazany do leczenia dorosłych pacjentów z nawracającą/oporną na leczenie rozproszonych chłoniak anaplastyczny (ДВККЛ), które nie są kandydatami do transplantacji krwiotwórczych komórek macierzystych przeszczep. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).

Unia Europejska - polski - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - inne leki na układ nerwowy - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Unia Europejska - polski - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - Środki przeciwnowotworowe - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

us pharmacia sp. z o.o. - paracetamolum + coffeinum - tabletki powlekane - 500 mg + 65 mg